RWML
AGN

RAFFA WEALTH MANAGEMENT, LLC’s Allergan plc AGN Stock Holding History

RAFFA WEALTH MANAGEMENT, LLC’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-25
Closed -$4.19K – 809
2019
Q2 		$4.19K Buy
+25
New +$3.46K ﹤0.01% 647

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RAFFA WEALTH MANAGEMENT, LLC's AGN Position: Q3 2019 in Review

RAFFA WEALTH MANAGEMENT, LLC sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 25 shares — an estimated $4.19K sold.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in AGN in Q2 2019 and held it in 1 quarter. The position peaked at $4.19K in Q2 2019. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • RAFFA WEALTH MANAGEMENT, LLC reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • RAFFA WEALTH MANAGEMENT, LLC sold 25 Allergan plc shares in Q3 2019, an estimated $4.19K.
  • RAFFA WEALTH MANAGEMENT, LLC first reported a position in Allergan plc in Q2 2019 and held it in 1 quarter.
  • RAFFA WEALTH MANAGEMENT, LLC's Allergan plc position peaked at $4.19K in Q2 2019.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q3 2019, filed 27 Jul 2026.